PT71842B - 17 alpha-alkylsteroide diese enthaltende praeparate sowie verfahren zu ihrer herstellung - Google Patents

17 alpha-alkylsteroide diese enthaltende praeparate sowie verfahren zu ihrer herstellung

Info

Publication number
PT71842B
PT71842B PT71842A PT7184280A PT71842B PT 71842 B PT71842 B PT 71842B PT 71842 A PT71842 A PT 71842A PT 7184280 A PT7184280 A PT 7184280A PT 71842 B PT71842 B PT 71842B
Authority
PT
Portugal
Prior art keywords
alkyl
alkenyl
alpha
alkylsteroids
preparates
Prior art date
Application number
PT71842A
Other languages
German (de)
English (en)
Portuguese (pt)
Other versions
PT71842A (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT71842A publication Critical patent/PT71842A/pt
Publication of PT71842B publication Critical patent/PT71842B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0044Alkenyl derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
PT71842A 1979-10-26 1980-09-26 17 alpha-alkylsteroide diese enthaltende praeparate sowie verfahren zu ihrer herstellung PT71842B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792943776 DE2943776A1 (de) 1979-10-26 1979-10-26 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
PT71842A PT71842A (de) 1980-10-01
PT71842B true PT71842B (de) 1981-07-09

Family

ID=6084722

Family Applications (1)

Application Number Title Priority Date Filing Date
PT71842A PT71842B (de) 1979-10-26 1980-09-26 17 alpha-alkylsteroide diese enthaltende praeparate sowie verfahren zu ihrer herstellung

Country Status (23)

Country Link
US (4) US4344941A (en, 2012)
EP (1) EP0027961B1 (en, 2012)
JP (1) JPS5673097A (en, 2012)
AT (1) ATE2221T1 (en, 2012)
AU (1) AU532515B2 (en, 2012)
CA (1) CA1160216A (en, 2012)
CS (1) CS228507B2 (en, 2012)
DD (1) DD153694A5 (en, 2012)
DE (2) DE2943776A1 (en, 2012)
DK (1) DK163002C (en, 2012)
EG (1) EG14998A (en, 2012)
ES (1) ES8106539A1 (en, 2012)
FI (1) FI69850C (en, 2012)
GR (1) GR71212B (en, 2012)
HU (1) HU183237B (en, 2012)
IE (1) IE52686B1 (en, 2012)
IL (1) IL61332A (en, 2012)
NO (1) NO154231C (en, 2012)
PL (1) PL125169B1 (en, 2012)
PT (1) PT71842B (en, 2012)
SU (1) SU973025A3 (en, 2012)
YU (1) YU256680A (en, 2012)
ZA (1) ZA806565B (en, 2012)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2943776A1 (de) * 1979-10-26 1981-05-14 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung
DE3115996A1 (de) * 1981-04-13 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen 17(alpha)-alkyl-17(beta)-hydroxy-1(alpha)- methyl-4-androsten-3-one-.verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
US5723502A (en) * 1985-07-18 1998-03-03 Proctor; Peter H. Topical spin trap composition and method
US5470876A (en) * 1985-07-18 1995-11-28 Proctor; Peter H. Topical sod for treating hair loss
US5728714A (en) * 1985-07-18 1998-03-17 Proctor; Peter H. Method for treating hair loss using tempo
US6150405A (en) * 1985-07-18 2000-11-21 Proctor; Peter H. Hair loss treatment with ascorbates
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
US5472687A (en) * 1985-07-18 1995-12-05 Proctor; Peter H. Topical pyridine N-oxides
US5714510A (en) * 1985-07-18 1998-02-03 Proctor; Peter H. Topical proxyl composition and method
US5716947A (en) * 1985-07-18 1998-02-10 Proctor; Peter H. Topical doxyl composition and method
US5714482A (en) * 1985-07-18 1998-02-03 Proctor; Peter H. Topical spin labels and method
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
DE3824247A1 (de) * 1988-07-13 1990-01-18 Schering Ag Neue androstan-derivate
EP0499779B1 (de) * 1991-01-24 1996-09-11 Rheinbraun Aktiengesellschaft Verfahren zum Behandeln von Abfällen
US5328686A (en) * 1991-10-30 1994-07-12 Douglas Shander Treatment of acne or of pseudofolliculitis barbae
ATE218273T1 (de) * 1991-11-05 2002-06-15 Gillette Co Veränderung der geschindigkeit und der art des haarwuchses
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
US5648394A (en) * 1993-05-27 1997-07-15 Boxall; Brian Alfred Topical composition for inhibiting hair growth
US6414017B2 (en) 1993-05-28 2002-07-02 The Gillette Company Inhibition of hair growth
US6248751B1 (en) 1993-05-28 2001-06-19 Gurpreet S. Ahluwalia Inhibition of hair growth
WO1995018821A2 (en) * 1994-01-06 1995-07-13 Sri International Novel antiandrogenic agents and related pharmaceutical compositions and methods of use
US5474763A (en) * 1994-03-11 1995-12-12 Shander; Douglas Reduction of hair growth
US5455234A (en) * 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
ES2175084T3 (es) * 1995-02-28 2002-11-16 Gillette Co Uso de supresores de angiogenesis para inhibir el crecimiento del pelo.
US5674477A (en) * 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
US5728736A (en) * 1995-11-29 1998-03-17 Shander; Douglas Reduction of hair growth
US5652273A (en) * 1995-11-30 1997-07-29 Henry; James Reduction of hair growth
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
US6294188B1 (en) 1998-07-09 2001-09-25 Aviana Biopharm Inc. Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
US20070129282A1 (en) * 1998-11-24 2007-06-07 Ahlem Clarence N Pharmaceutical treatments and compositions
PT1955700E (pt) * 1999-09-30 2011-05-04 Harbor Biosciences Inc Tratamento terap?utico de doen?as associadas ao receptor de androg?nios
US7285109B2 (en) * 2003-02-13 2007-10-23 Boston Scientific Scimed, Inc. Device and method for collapsing an angioplasty balloon
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
MX2011011833A (es) 2009-05-06 2012-01-27 Lab Skin Care Inc Composiciones de administración dérmica que comprenden complejos de partículas de fosfato de calcio-agente activo y métodos para utilizar las mismas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1382468A (fr) * 1964-01-28 1964-12-18 Spofa Vereinigte Pharma Werke Procédé de préparation des composés de 3-céto-androstane 1-méthyle-substitués, et produits conformes à ceux obtenus par le présent procédé ou procédé similaire
US3391168A (en) * 1965-08-23 1968-07-02 Searle & Co 1, 17-dimethyl-5-androstane-3beta, 17beta-diol and esters thereof
US3705180A (en) * 1971-09-02 1972-12-05 Paul D Klimstra 17-oxygenate-2-alpha-methyl-2-methylen-5 alpha-androstan-3-ones and intermediates
US4039669A (en) * 1975-08-01 1977-08-02 Sterling Drug Inc. Composition for topical application and use thereof
DE2943776A1 (de) * 1979-10-26 1981-05-14 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NO154231B (no) 1986-05-05
CA1160216A (en) 1984-01-10
PL227468A1 (en, 2012) 1981-07-10
JPH0153280B2 (en, 2012) 1989-11-13
IE52686B1 (en) 1988-01-20
US4558041A (en) 1985-12-10
SU973025A3 (ru) 1982-11-07
US4344941A (en) 1982-08-17
ZA806565B (en) 1981-10-28
EP0027961A1 (de) 1981-05-06
DK163002B (da) 1992-01-06
FI803342L (fi) 1981-04-27
PT71842A (de) 1980-10-01
PL125169B1 (en) 1983-04-30
NO803172L (no) 1981-04-27
HU183237B (en) 1984-04-28
AU6363780A (en) 1981-04-30
CS228507B2 (en) 1984-05-14
ATE2221T1 (de) 1983-01-15
DE2943776A1 (de) 1981-05-14
ES495740A0 (es) 1981-06-16
NO154231C (no) 1986-08-13
GR71212B (en, 2012) 1983-04-11
DK434380A (da) 1981-04-27
US4892867A (en) 1990-01-09
FI69850C (fi) 1986-05-26
DE3061638D1 (en) 1983-02-17
AU532515B2 (en) 1983-10-06
IE802202L (en) 1981-04-26
US4456600A (en) 1984-06-26
DK163002C (da) 1992-06-01
FI69850B (fi) 1985-12-31
IL61332A0 (en) 1980-12-31
EP0027961B1 (de) 1983-01-12
EG14998A (en) 1985-06-30
ES8106539A1 (es) 1981-06-16
JPS5673097A (en) 1981-06-17
DD153694A5 (de) 1982-01-27
YU256680A (en) 1983-02-28
IL61332A (en) 1985-05-31

Similar Documents

Publication Publication Date Title
PT71842B (de) 17 alpha-alkylsteroide diese enthaltende praeparate sowie verfahren zu ihrer herstellung
ATE1814T1 (de) 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung.
ES472147A1 (es) Procedimiento para la preparacion de nuevos esteroido-17- alcohilcarbonatos.
YU245276A (en) Process for obtaining 15-steroids
PT78743B (de) 1-alkyl-androsta-1,4-dien-3,17-dione verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
ES485098A1 (es) Derivados de dibenzotiepin y un proceso para la produccion- del mismo.
US4582857B1 (en) P-oxybenzoic acid derivatives processes for their production and their use as drugs
HUT50845A (en) Process for producing 14,17beta-ethano-14beta-estratrienes and pharmaceutical compositions comprising same
ATE16108T1 (de) Steroide die, in stellung 17 verestert sind, und in stellung 21 eine thioestergruppe enthalten, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
DE3563971D1 (en) 1-alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them
IE781753L (en) Steroid 3-oximes
ATE430T1 (de) 16-alpha-alkylsteroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE3481707D1 (de) 7-alpha-substituierte 3-oxo-17alpha-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE15898T1 (de) Neue n-substitierte polyglycidylurazolverbindungen, verfahren zu ihrer herstellung sowie pharmazeutische zubereitungen.
ATE429T1 (de) 11-methylensteroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ES8204741A1 (es) Procedimiento para la preparacion de 3-desoxi-a15-esteroides
DE59008713D1 (de) Verfahren zur herstellung von 21-brom-4-pregnen-3,20-dion-derivaten.
CH610887A5 (en) Process for the preparation of new 7-benzoyl-2-indolinones
DE3061199D1 (en) 12-alpha-hydroxy steroids and their preparation